Atul Limited

Atul Limited

Atul Limited has informed the Exchange about change in Management, with Dr Dhaval Vashi taking over as Senior Vice President, Pharmaceuticals, and Mr Vinay Desai becoming President, Technology and Manufacturing, effective July 18, 2026.

Atul Limited

Atul Limited has informed the Exchange about the dispatch of the integrated annual report for 2025-26, including the Notice of 49th Annual General Meeting and procedure for e-voting, through a newspaper advertisement.

Atul Limited

Atul Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018, confirming the dematerialisation of securities during the quarter ended June 30, 2026.

Atul Limited

Atul Limited has submitted its Business Responsibility and Sustainability Report 2025-26, which forms part of its integrated annual report for the same period.

Atul Limited

Atul Limited has informed the Exchange about General Updates regarding the Integrated annual report 2025-26 and the 49th Annual General Meeting (AGM) scheduled to be held on July 31, 2026. The company has also recommended a dividend of ₹ 30 per equity share for the financial year ended on March 31, 2026, subject to approval by the members at the AGM.

Atul Limited

Atul Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 31, 2026.

Atul Limited

Atul Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015, ahead of the Board of Directors meeting on July 24, 2026, to consider unaudited standalone and consolidated financial results for the first quarter ending on June 30, 2026.